GlassScriptPhysician profile
Steven W Luke
NPI 1285676189
$7,503.43
in general payments reported to CMS, 2019-2025
48 companies · $1,611 in 2025
The $1,611 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $352 · 2021: $1,006 · 2022: $1,401 · 2023: $1,213 · 2024: $1,273 · 2025: $1,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,994 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,993.65 |
| Education | $103.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $563.79 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $561.20 | 2019-2025 | Ams 700, Rezum Generator, Ams 700 Cxr Rte Kit |
| Medtronic, INC. | $488.82 | 2021-2025 | Altaviva, Interstim |
| Sumitomo Pharma America, INC. | $466.48 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $381.47 | 2021-2025 | |
| Pfizer INC. | $372.59 | 2021-2025 | |
| Janssen Biotech, INC. | $365.58 | 2019-2025 | Erleada |
| Axonics, INC. | $291.63 | 2022-2023 | Bulkamid, Axonics |
| Merck Sharp & Dohme LLC | $282.42 | 2022-2025 | Lynparza, Keytruda |
| Dendreon Pharmaceuticals LLC | $276.54 | 2019-2025 | Provenge |
| Coloplast Corp | $256.44 | 2019-2025 | Titan, Speedicath |
| Antares Pharma, INC. | $232.60 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $225.76 | 2019-2024 | Aveed, Xiaflex |
| Teleflex LLC | $210.94 | 2021-2025 | Urolift, Barrigel |
| Neotract INC. | $205.82 | 2019-2020 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $195.21 | 2021-2025 | Pylarify |
| Blue Earth Diagnostics | $192.26 | 2024-2025 | Posluma |
| Urogen Pharma, INC. | $191.50 | 2022-2025 | Jelmyto |
| Ferring Pharmaceuticals INC. | $175.77 | 2019-2025 | Adstiladrin |
| Medtronic USA, INC. | $136.94 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $117.88 | 2021-2023 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $107.16 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $106.41 | 2022-2025 | Imfinzi |
| Angiodynamics, INC. | $100.70 | 2025 | Nanoknife |
| Agiliti Surgical, INC. | $88.04 | 2022 | |
| Calyxo, INC. | $83.82 | 2025 | Cvac Aspiration System |
| Clarus Therapeutics INC. | $75.30 | 2021 | |
| Tolmar, INC. | $63.79 | 2023-2025 | Eligard, Jatenzo |
| Laborie Medical Technologies Corp. | $59.09 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Tempus Ai, INC | $58.83 | 2024-2025 | Xt Cdx, Tempus Pixel |
| Novartis Pharmaceuticals Corporation | $58.51 | 2024-2025 | |
| 180 Medical, INC. | $56.81 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $49.65 | 2021 | |
| Baxter Healthcare | $46.57 | 2024 | Floseal |
| Telix Pharmaceuticals | $40.62 | 2024 | Illuccix |
| Urovant Sciences INC | $38.01 | 2021-2022 | |
| Rgh Enterprises LLC | $36.18 | 2019 | |
| Accord Healthcare, INC. | $32.97 | 2024 | |
| Hollister Incorporated | $29.24 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $28.82 | 2019-2021 | |
| Endo USA, INC. | $23.86 | 2024 | Xiaflex |
| Procept Biorobotics Corporation | $21.27 | 2024 | Aquabeam System |
| Olympus America INC. | $20.45 | 2023 | Itind System |
| Halozyme INC | $19.85 | 2023 | |
| Hologic Sales and Service, LLC | $19.58 | 2024 | Aptima |
| Aytu Biopharma, INC. | $17.75 | 2019 | |
| Allergan, INC. | $14.43 | 2021 | |
| Immunitybio, INC. | $14.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Luke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.